These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 6128460)
21. Disorders of the basal ganglia and their modern management. Schrag A; Quinn N J R Coll Physicians Lond; 1999; 33(4):323-7. PubMed ID: 10472019 [No Abstract] [Full Text] [Related]
22. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism. Brogden RN; Speight TM; Avery GS Drugs; 1971; 2(4):262-400. PubMed ID: 4340597 [No Abstract] [Full Text] [Related]
23. The pathogensis and medical treatment of extrapyramidal disease. Calne DB; Eisler T Med Clin North Am; 1979 Jul; 63(4):715-27. PubMed ID: 157413 [No Abstract] [Full Text] [Related]
24. End of lines and boxes. Albin RL Mov Disord; 2001 May; 16(3):405-6. PubMed ID: 11391733 [No Abstract] [Full Text] [Related]
25. [Clinical picture and treatment of Parkinson-like syndromes of hereditary etiology]. Markova ED; Ivanova-Smolenskaia IA; Insarova NG; Barkhatova VP Klin Med (Mosk); 1978 Sep; 56(9):104-11. PubMed ID: 151762 [No Abstract] [Full Text] [Related]
26. Aetiology and natural history of Parkinson's disease. Pearce JM Br Med J; 1978 Dec; 2(6153):1664-6. PubMed ID: 32952 [No Abstract] [Full Text] [Related]
27. The current model of basal ganglia organization under scrutiny. Parent A; Cicchetti F Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330 [No Abstract] [Full Text] [Related]
28. The expanding universe of disorders of the basal ganglia. Obeso JA; Rodriguez-Oroz MC; Stamelou M; Bhatia KP; Burn DJ Lancet; 2014 Aug; 384(9942):523-31. PubMed ID: 24954674 [TBL] [Abstract][Full Text] [Related]
30. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder. Wray SR; Melville GN; Grell GA; Edge PC West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153 [No Abstract] [Full Text] [Related]
31. Movement disorders--limb movement and the basal ganglia. Stelmach GE; Phillips JG Phys Ther; 1991 Jan; 71(1):60-7. PubMed ID: 1824578 [TBL] [Abstract][Full Text] [Related]
32. A new striatal model and its relationship to basal ganglia diseases. Connolly CI; Burns JB Neurosci Res; 1993 May; 16(4):271-4. PubMed ID: 8394554 [TBL] [Abstract][Full Text] [Related]
33. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related]
34. Functional anatomy of movement disorders. Crossman AR J Anat; 2000 May; 196 ( Pt 4)(Pt 4):519-25. PubMed ID: 10923984 [TBL] [Abstract][Full Text] [Related]
35. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Strange PG Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967 [TBL] [Abstract][Full Text] [Related]
36. [Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry]. Bartholini G Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):265-9. PubMed ID: 45343 [TBL] [Abstract][Full Text] [Related]
37. The pharmacology of tardive dyskinesias. Klawans HL Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755 [No Abstract] [Full Text] [Related]